CASE PhD Studentship. Developing selective PDE4B-targeting PROTACs

RSEQ; Lancaster; Hybrid; GBP 21,000 - 25,000; Full time

Benefits offered by this job

CASE Studentship

AstraZeneca placement

Industry collaboration

Job summary

Lancaster University in collaboration with AstraZeneca offers a CASE PhD Studentship starting October 2027 in the Chemistry Department. The project focuses on developing selective PDE4B-targeting PROTACs to modulate inflammation and improve animal health, with training in medicinal chemistry, chemical biology and drug discovery.

This fully funded project includes an industrial collaboration with AstraZeneca and a 3-month placement at AstraZeneca, providing hands-on experience and exposure to

Job description

A CASE PhD Studentship is available in the group of Dr Maria Paz Muñoz at the Chemistry Department at Lancaster University in collaboration with Neil Dawson and Andrew Fielding at the Lancaster University | Biomedical & Life Sciences and AstraZeneca for October 2027 start.

Title of the project: Developing selective PDE4B-targeting PROTACs to modulate inflammation and improve animal health ( https://lnkd.in/e3XzVMdh ).

This is an exciting new project to develop innovative PDE4B-targeting PROTACs to tackle inflammation and improve animal health.The project fully funded by NorthWestBio CASE Studentship and offers: industrial collaboration with AstraZeneca,3-month placement at AstraZeneca and training in medicinal chemistry, chemical biology and drug discovery

Any queries can be directed to [e-mail].